Atkinson, Thomas M. https://orcid.org/0000-0002-4965-3913
Lensing, Shelly
Lee, Jeannette Y.
Chang, Di
Kim, Soo Young
Li, Yuelin
Lynch, Kathleen A.
Webb, Andrew
Holland, Susan M.
Lubetkin, Erica I.
Goldstone, Stephen
Einstein, Mark H.
Stier, Elizabeth A.
Wiley, Dorothy J.
Mitsuyasu, Ronald
Rosa-Cunha, Isabella
Aboulafia, David M.
Dhanireddy, Shireesha
Schouten, Jeffrey T.
Levine, Rebecca
Gardner, Edward
Logan, Jeffrey
Dunleavy, Hillary
Barroso, Luis F.
Bucher, Gary
Korman, Jessica
Stearn, Benjamin
Wilkin, Timothy J.
Ellsworth, Grant
Pugliese, Julia C.
Arons, Abigail
Burkhalter, Jack E.
Cella, David
Berry-Lawhorn, J. Michael
Palefsky, Joel M.
Funding for this research was provided by:
NIH (2 UM1 CA121947-09, 3U54CA137788-08S1, P30 CA008748)
Article History
Accepted: 4 March 2023
First Online: 5 April 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the NCI’s Cancer Therapy Evaluation Program and Institutional Review Boards at each study site.
: For the construct validity phase, verbal consent was obtained from all included participants. Informed consent was obtained from all participants in the responsiveness phase.